These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22614990)

  • 21. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH; Rasmussen PC; Laurberg S
    Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-67.
    Sugarbaker PH
    J Surg Oncol; 2004 Dec; 88(4):276-8. PubMed ID: 15565559
    [No Abstract]   [Full Text] [Related]  

  • 24. Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.
    Kemmel V; Mercoli HA; Meyer N; Brumaru D; Romain B; Lessinger JM; Brigand C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S873-9. PubMed ID: 26100819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases.
    Yun JA; Park Y; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    J Surg Oncol; 2014 Dec; 110(7):839-44. PubMed ID: 25043872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis.
    Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Jul; 14(7):2171-2. PubMed ID: 17453299
    [No Abstract]   [Full Text] [Related]  

  • 27. Peritoneal carcinomatosis.
    Noguchi M
    Ann Surg; 1995 Dec; 222(6):760-1. PubMed ID: 8526584
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.
    Elias D; Delperro JR; Sideris L; Benhamou E; Pocard M; Baton O; Giovannini M; Lasser P
    Ann Surg Oncol; 2004 May; 11(5):518-21. PubMed ID: 15123461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study.
    Chua TC; Morris DL; Saxena A; Esquivel J; Liauw W; Doerfer J; Germer CT; Kerscher AG; Pelz JO
    Ann Surg Oncol; 2011 Jun; 18(6):1560-7. PubMed ID: 21203904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care.
    Sugarbaker PH
    Surg Oncol Clin N Am; 2012 Oct; 21(4):689-703. PubMed ID: 23021724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Totally implantable systems in colorectal tumors. The locoregional chemotherapy of hepatic and peritoneal metastases].
    Ciaccio V; Bufalari A; Ferri M; Giustozzi GM
    Minerva Chir; 1992 Apr; 47(7):621-5. PubMed ID: 1589121
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients.
    Moran BJ; Meade B; Murphy E
    Colorectal Dis; 2006 Sep; 8(7):544-50. PubMed ID: 16919104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected Findings in a Patient With Cancer of Unknown Primary Syndrome.
    Lübbert C; Holler B
    Gastroenterology; 2018 Feb; 154(3):491-492. PubMed ID: 29352954
    [No Abstract]   [Full Text] [Related]  

  • 34. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.
    Passot G; You B; Boschetti G; Fontaine J; Isaac S; Decullier E; Maurice C; Vaudoyer D; Gilly FN; Cotte E; Glehen O
    Ann Surg Oncol; 2014 Aug; 21(8):2608-14. PubMed ID: 24668148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL
    Am J Surg; 2011 Feb; 201(2):149-56. PubMed ID: 20832051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
    Tomoda M; Kawahara H; Watanabe K; Enomoto H; Akiba T; Yanaga K
    Anticancer Res; 2014 Jan; 34(1):191-4. PubMed ID: 24403461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Hingh IH; Creemers GJ
    Clin Colorectal Cancer; 2016 Jun; 15(2):e41-6. PubMed ID: 26762572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical predictive factors.
    Köhne CH; Vanhoefer U; Hartung G
    Eur J Cancer; 2009 Sep; 45 Suppl 1():43-9. PubMed ID: 19775603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.